Bionano Genomics (BNGO) Goodwill (2020 - 2023)

Bionano Genomics has disclosed Goodwill across 4 years of filings, most recently posting $77.3 million for Q2 2023.

• Goodwill for Q2 2023 came in at $77.3 million, up 37.38% year-over-year; the trailing twelve-month figure through Jun 2023 was $77.3 million (up 37.38% YoY), and the FY2022 annual result was $77.3 million, up 37.62% from the prior year.
• Goodwill came in at $77.3 million for Q2 2023 at Bionano Genomics, roughly flat from $77.3 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $77.3 million in Q4 2022 to a low of $6.9 million in Q3 2020.
• The 4-year median for Goodwill is $56.2 million (2021), against an average of $41.1 million.
• Across the five-year window, Goodwill advanced 3.34% in 2021 and surged 687.2% in 2022, its largest moves.
• Bionano Genomics' Goodwill stood at $7.2 million in 2020, then surged by 682.94% to $56.2 million in 2021, then surged by 37.62% to $77.3 million in 2022, then retreated by 0.01% to $77.3 million in 2023.
• The last three Goodwill figures came in at $77.3 million (Q2 2023), $77.3 million (Q1 2023), and $77.3 million (Q4 2022), per Business Quant data.